Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma

NY-ESO-1 is a cancer-testis antigen aberrantly expressed in melanomas, which may serve as a robust and specific target in immunotherapy. NY-ESO-1 antigen expression, tumor features, and the immune profile of tumor infiltrating lymphocytes were assessed in primary cutaneous melanoma. NY-ESO-1 protein...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunol Res
Main Authors: Giavina-Bianchi, Mara, Giavina-Bianchi, Pedro, Sotto, Mirian Nacagami, Muzikansky, Alona, Kalil, Jorge, Festa-Neto, Cyro, Duncan, Lyn M.
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2015
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4411457/
https://ncbi.nlm.nih.gov/pubmed/25954764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/761378
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki